المؤلفون: Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Grover P; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio., Awosika J; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio., Gulati S; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio., Hsu CY; Vanderbilt University Medical Center, Nashville, Tennessee., Alimohamed SI; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina., Bashir B; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Berg S; Loyola University Medical Center, Maywood, Illinois., Bilen MA; Winship Cancer Institute, Emory University, Atlanta, Georgia., Bowles D; University of Colorado, Denver., Castellano C; Winship Cancer Institute, Emory University, Atlanta, Georgia., Desai A; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Elkrief A; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Eton OE; Hartford Healthcare Cancer Institute, Hartford, Connecticut., Fecher LA; University of Michigan Rogel Cancer Center, Ann Arbor., Flora D; St. Elizabeth Health Care, Edgewood, Kentucky., Galsky MD; Tisch Cancer Institute, Mount Sinai, New York., Gatti-Mays ME; Division of Medical Oncology, The Ohio State University, Columbus., Gesenhues A; St. Elizabeth Health Care, Edgewood, Kentucky., Glover MJ; Stanford University, Stanford, California., Gopalakrishnan D; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Gupta S; Cleveland Clinic, Cleveland, Ohio., Halfdanarson TR; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Hayes-Lattin B; Knight Cancer Institute, Oregon Health and Science University, Portland., Hendawi M; Aurora Cancer Center, Advocate Aurora Health, Milwaukee, Wisconsin., Hsu E; Hartford Healthcare Cancer Institute, Hartford, Connecticut., Hwang C; Henry Ford Cancer Institute, Detroit, Michigan., Jandarov R; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio., Jani C; Mt. Auburn Hospital, Boston, Massachusetts., Johnson DB; Vanderbilt University Medical Center, Nashville, Tennessee., Joshi M; Penn State Cancer Institute, Hershey, Pennsylvania., Khan H; Brown University and Lifespan Cancer Institute, Providence, Rhode Island., Khan SA; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York., Knox N; Loyola University Medical Center, Maywood, Illinois., Koshkin VS; UCSF, Helen Diller Comprehensive Cancer Center, San Francisco., Kulkarni AA; Masonic Cancer Center, University of Minnesota, Minneapolis., Kwon DH; UCSF, Helen Diller Comprehensive Cancer Center, San Francisco., Matar S; Hollings Cancer Center, MUSC, Charleston., McKay RR; Moores Cancer Center, UCSD, San Diego, California., Mishra S; Vanderbilt University Medical Center, Nashville, Tennessee., Moria FA; McGill University Health Centre, Montreal, Quebec, Canada., Nizam A; Cleveland Clinic, Cleveland, Ohio., Nock NL; Case Comprehensive Cancer Center, Department of Population and Quantitative Health Sciences, Cleveland, Ohio., Nonato TK; Moores Cancer Center, UCSD, San Diego, California., Panasci J; Jewish General Hospital, McGill University, Montreal, Quebec, Canada., Pomerantz L; Penn State Cancer Institute, Hershey, Pennsylvania., Portuguese AJ; Fred Hutchinson Cancer Research Center, Seattle, Washington., Provenzano D; George Washington University, Washington, DC., Puc M; Virtua Health, Marlton, New Jersey., Rao YJ; George Washington University, Washington, DC., Rhodes TD; Intermountain Healthcare, Salt Lake City, Utah., Riely GJ; Memorial Sloan Kettering Cancer Center, New York., Ripp JJ; University of Kansas Medical Center, Kansas City., Rivera AV; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Ruiz-Garcia E; Instituto Nacional de Cancerologia, Mexico., Schmidt AL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schoenfeld AJ; Memorial Sloan Kettering Cancer Center, New York., Schwartz GK; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York., Shah SA; Stanford University, Stanford, California., Shaya J; Moores Cancer Center, UCSD, San Diego, California., Subbiah S; Stanley S. Scott Cancer Center, LSU, New Orleans, Louisiana., Tachiki LM; Fred Hutchinson Cancer Research Center, Seattle, Washington., Tucker MD; Vanderbilt University Medical Center, Nashville, Tennessee., Valdez-Reyes M; Instituto Nacional de Cancerologia, Mexico., Weissmann LB; Mt. Auburn Hospital, Boston, Massachusetts., Wotman MT; Tisch Cancer Institute, Mount Sinai, New York., Wulff-Burchfield EM; University of Kansas Medical Center, Kansas City., Xie Z; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Yang YJ; Vanderbilt University Medical Center, Nashville, Tennessee., Thompson MA; Aurora Cancer Center, Advocate Aurora Health, Milwaukee, Wisconsin.; Tempus Labs, Chicago, Illinois., Shah DP; Mays Cancer Center, UT Health, San Antonio, Texas., Warner JL; Vanderbilt University Medical Center, Nashville, Tennessee., Shyr Y; Vanderbilt University Medical Center, Nashville, Tennessee., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wise-Draper TM; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio.

مؤلفون مشاركون: COVID-19 and Cancer Consortium

المصدر: JAMA oncology [JAMA Oncol] 2023 Jan 01; Vol. 9 (1), pp. 128-134.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/epidemiology , Neoplasms*/epidemiology , Neoplasms*/therapy, Humans ; Female ; Middle Aged ; Aged ; Male ; SARS-CoV-2 ; Cohort Studies ; Retrospective Studies ; COVID-19 Testing ; Cytokine Release Syndrome/etiology ; Immunosuppression Therapy ; Immunotherapy/adverse effects

المؤلفون: Rubinstein SM; Division of Hematology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina., Bhutani D; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York., Lynch RC; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington., Hsu CY; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Shyr Y; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee., Advani S; Cancer Prevention and Control, Department of Oncology, Georgetown University School of Medicine, Georgetown University, Washington D.C., Mesa RA; Mays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, Texas., Mishra S; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Mundt DP; Aurora Cancer Care, Advocate Aurora Health, Milwaukee, Wisconsin., Shah DP; Mays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, Texas., Sica RA; Division of Hematology and Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York., Stockerl-Goldstein KE; Division of Oncology, Washington University, Saint Louis, Missouri., Stratton C; Division of Hematology and Oncology, Yale University, New Haven, Connecticut., Weiss M; Thedacare, Appleton, Wisconsin., Beeghly-Fadiel A; Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee., Accordino M; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York., Assouline SE; Division of Hematology, McGill University, Jewish General Hospital, Montreal, Quebec, Canada., Awosika J; University of Cincinnati Cancer Center, Cincinnati, Ohio., Bakouny Z; Dana-Farber Cancer Institute, Boston, Massachusetts., Bashir B; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Berg S; Division of Hematology and Oncology, Loyola University Medical Center, Hines, Illinois., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, Georgia., Castellano CA; Winship Cancer Institute of Emory University, Atlanta, Georgia., Cogan JC; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York., Kc D; Hartford HealthCare Cancer Institute, Hartford, Connecticut., Friese CR; University of Michigan Rogel Cancer Center, Ann Arbor, Michigan., Gupta S; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Hausrath D; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Hwang C; Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan., Johnson NA; Division of Hematology, McGill University, Jewish General Hospital, Montreal, Quebec, Canada., Joshi M; Penn State Health/Penn State Cancer Institute/St. Joseph Cancer Center, Philadelphia, Pennsylvania., Kasi A; The University of Kansas Cancer Center, Kansas City, Kansas., Klein EJ; Brown University and Lifespan Cancer Institute, Providence, Rhode Island., Koshkin VS; Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California., Kuderer NM; Advanced Cancer Research Group, Seattle, Washington., Kwon DH; Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California., Labaki C; Dana-Farber Cancer Institute, Boston, Massachusetts., Latif T; University of Cincinnati Cancer Center, Cincinnati, Ohio., Lau E; Division of Medical Oncology and Hematology, Loma Linda University, Loma Linda, California., Li X; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Lyman GH; Fred Hutchinson Cancer Research Center, Seattle, Washington., McKay RR; Moores Comprehensive Cancer Center, University of California, San Diego, San Diego, California., Nagaraj G; Division of Medical Oncology and Hematology, Loma Linda University, Loma Linda, California., Nizam A; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Nonato TK; Moores Comprehensive Cancer Center, University of California, San Diego, San Diego, California., Olszewski AJ; Brown University and Lifespan Cancer Institute, Providence, Rhode Island., Polimera HV; Penn State Health/Penn State Cancer Institute/St. Joseph Cancer Center, Philadelphia, Pennsylvania., Portuguese AJ; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington., Puc MM; Virtua Health, Marlton, New Jersey., Razavi P; Moores Comprehensive Cancer Center, University of California, San Diego, San Diego, California., Rosovski R; Division of Hematology, Massachusetts General Hospital, Boston, Massachusetts., Schmidt A; Dana-Farber Cancer Institute, Boston, Massachusetts., Shah SA; Stanford Cancer Institute at Stanford University, Stanford, California., Shastri A; Division of Hematology and Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York., Su C; University of Michigan Rogel Cancer Center, Ann Arbor, Michigan., Torka P; Roswell Park Comprehensive Cancer Center, New York, New York., Wise-Draper TM; University of Cincinnati Cancer Center, Cincinnati, Ohio., Zubiri L; Virtua Health, Marlton, New Jersey., Warner JL; Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Thompson MA; Aurora Cancer Care, Advocate Aurora Health, Milwaukee, Wisconsin.

مؤلفون مشاركون: COVID-19 and Cancer Consortium

المصدر: Blood cancer discovery [Blood Cancer Discov] 2022 May 05; Vol. 3 (3), pp. 181-193.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/epidemiology , Lymphatic Diseases* , Neoplasms*/epidemiology, COVID-19 Testing ; Humans ; Risk Factors ; SARS-CoV-2

المؤلفون: Hawley JE; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York.; now with Division of Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle., Sun T; Vanderbilt University Medical Center, Nashville, Tennessee., Chism DD; Thompson Cancer Survival Center, Knoxville, Tennessee., Duma N; University of Wisconsin Carbone Cancer Center, Madison., Fu JC; Tufts Medical Center Cancer Center, Boston and Stoneham, Massachusetts., Gatson NTN; Geisinger Health System, Danville, Pennsylvania.; Banner MD Anderson Cancer Center, Gilbert, Arizona., Mishra S; Vanderbilt University Medical Center, Nashville, Tennessee., Nguyen RH; University of Illinois Hospital & Health Sciences System, Chicago., Reid SA; Vanderbilt University Medical Center, Nashville, Tennessee., Serrano OK; Hartford HealthCare Cancer Institute, Hartford, Connecticut., Singh SRK; Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan., Venepalli NK; University of North Carolina, Lineberger Cancer Center, Chapel Hill., Bakouny Z; Dana-Farber Cancer Institute, Boston, Massachusetts., Bashir B; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, Georgia., Caimi PF; Case Comprehensive Cancer Center at Case Western Reserve University/University Hospitals, Cleveland, Ohio., Choueiri TK; Dana-Farber Cancer Institute, Boston, Massachusetts., Dawsey SJ; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Fecher LA; University of Michigan Rogel Cancer Center, Ann Arbor., Flora DB; St Elizabeth Healthcare, Edgewood, Kentucky., Friese CR; University of Michigan Rogel Cancer Center, Ann Arbor., Glover MJ; Stanford Cancer Institute at Stanford University, Palo Alto, California., Gonzalez CJ; University of Michigan Rogel Cancer Center, Ann Arbor., Goyal S; George Washington University, Washington, DC., Halfdanarson TR; Mayo Clinic, Rochester, Minnesota., Hershman DL; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York., Khan H; Brown University and Lifespan Cancer Institute, Providence, Rhode Island., Labaki C; Dana-Farber Cancer Institute, Boston, Massachusetts., Lewis MA; Intermountain Healthcare, Salt Lake City, Utah., McKay RR; University of California, San Diego., Messing I; George Washington University, Washington, DC., Pennell NA; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Puc M; Virtua Health, Marlton, New Jersey., Ravindranathan D; Winship Cancer Institute of Emory University, Atlanta, Georgia., Rhodes TD; Intermountain Healthcare, Salt Lake City, Utah., Rivera AV; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania., Roller J; University of Kansas Medical Center, Kansas City., Schwartz GK; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York., Shah SA; Stanford Cancer Institute at Stanford University, Palo Alto, California., Shaya JA; University of California, San Diego., Streckfuss M; Advocate Aurora Health, Milwaukee, Wisconsin., Thompson MA; Advocate Aurora Health, Milwaukee, Wisconsin., Wulff-Burchfield EM; University of Kansas Medical Center, Kansas City., Xie Z; Mayo Clinic, Rochester, Minnesota., Yu PP; Hartford HealthCare Cancer Institute, Hartford, Connecticut., Warner JL; Vanderbilt University Medical Center, Nashville, Tennessee., Shah DP; Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas., French B; Vanderbilt University Medical Center, Nashville, Tennessee., Hwang C; Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan.

مؤلفون مشاركون: COVID-19 and Cancer Consortium (CCC19)

المصدر: JAMA network open [JAMA Netw Open] 2022 Jan 04; Vol. 5 (1), pp. e2142046. Date of Electronic Publication: 2022 Jan 04.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Pandemics* , Rural Population* , Social Vulnerability* , Urban Population*, COVID-19/*epidemiology , Neoplasms/*epidemiology, Aged ; Cause of Death ; Censuses ; Female ; Health Facilities ; Humans ; Intensive Care Units ; Male ; Middle Aged ; Odds Ratio ; Registries ; Respiration, Artificial ; Retrospective Studies ; Risk Factors ; SARS-CoV-2 ; Severity of Illness Index ; Spatial Analysis ; United States/epidemiology

المؤلفون: Grivas P; University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, USA. Electronic address: pgrivas@uw.edu., Khaki AR; University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, USA; Stanford University, Stanford, USA., Wise-Draper TM; University of Cincinnati Cancer Center, Cincinnati, USA., French B; Vanderbilt University Medical Center, Nashville, USA., Hennessy C; Vanderbilt University Medical Center, Nashville, USA., Hsu CY; Vanderbilt University Medical Center, Nashville, USA., Shyr Y; Vanderbilt University Medical Center, Nashville, USA., Li X; Vanderbilt University School of Medicine, Nashville, USA., Choueiri TK; Dana-Farber Cancer Institute, Boston, USA., Painter CA; Broad Institute, Cancer Program, Cambridge, USA., Peters S; Lausanne University, Lausanne, Switzerland., Rini BI; Vanderbilt University Medical Center, Nashville, USA., Thompson MA; Advocate Aurora Health, Milwaukee, USA., Mishra S; Vanderbilt University Medical Center, Nashville, USA., Rivera DR; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, USA., Acoba JD; University of Hawaii Cancer Center, Honolulu, USA., Abidi MZ; University of Colorado School of Medicine, Aurora, USA., Bakouny Z; Dana-Farber Cancer Institute, Boston, USA., Bashir B; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, USA., Bekaii-Saab T; Mayo Clinic Cancer Center, Phoenix, USA., Berg S; Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, USA., Bernicker EH; Houston Methodist Cancer Center, Houston, USA., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, USA., Bindal P; Beth Israel Deaconess Medical Center, Boston, USA., Bishnoi R; University of Florida, Gainesville, USA., Bouganim N; McGill University Health Centre, Montréal, Canada., Bowles DW; University of Colorado School of Medicine, Aurora, USA., Cabal A; University of California San Diego, Moores Cancer Center, La Jolla, USA., Caimi PF; University Hospitals Seidman Cancer Center, Cleveland, USA; Case Western Reserve University, Cleveland, USA., Chism DD; Thompson Cancer Survival Center, Knoxville, USA., Crowell J; St. Elizabeth Healthcare, Edgewood, USA., Curran C; Dana-Farber Cancer Institute, Boston, USA., Desai A; Mayo Clinic Cancer Center, Rochester, USA., Dixon B; St. Elizabeth Healthcare, Edgewood, USA., Doroshow DB; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Durbin EB; Markey Cancer Center, University of Kentucky, Lexington, USA., Elkrief A; McGill University Health Centre, Montréal, Canada., Farmakiotis D; The Warren Alpert Medical School of Brown University, Providence, USA., Fazio A; Tufts Medical Center Cancer Center, Boston and Stoneham, USA., Fecher LA; University of Michigan Rogel Cancer Center, Ann Arbor, USA., Flora DB; St. Elizabeth Healthcare, Edgewood, USA., Friese CR; University of Michigan Rogel Cancer Center, Ann Arbor, USA., Fu J; Tufts Medical Center Cancer Center, Boston and Stoneham, USA., Gadgeel SM; Henry Ford Cancer Institute/Henry Ford Health System, Detroit, USA., Galsky MD; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Gill DM; Intermountain Healthcare, Salt Lake City, USA., Glover MJ; Stanford University, Stanford, USA., Goyal S; George Washington University, Washington DC, USA., Grover P; University of Cincinnati Cancer Center, Cincinnati, USA., Gulati S; University of Cincinnati Cancer Center, Cincinnati, USA., Gupta S; Cleveland Clinic Taussig Cancer Institute, Cleveland, USA., Halabi S; Duke University, Durham, USA., Halfdanarson TR; Mayo Clinic Cancer Center, Rochester, USA., Halmos B; Albert Einstein Cancer Center/Montefiore Medical Center, Bronx, USA., Hausrath DJ; Vanderbilt University School of Medicine, Nashville, USA., Hawley JE; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, USA., Hsu E; Hartford HealthCare, Hartford, USA; University of Connecticut, Farmington, USA., Huynh-Le M; George Washington University, Washington DC, USA., Hwang C; Henry Ford Cancer Institute/Henry Ford Health System, Detroit, USA., Jani C; Mount Auburn Hospital, Cambridge, USA., Jayaraj A; Hartford HealthCare, Hartford, USA., Johnson DB; Vanderbilt University Medical Center, Nashville, USA., Kasi A; University of Kansas Medical Center, Kansas City, USA., Khan H; The Warren Alpert Medical School of Brown University, Providence, USA., Koshkin VS; University of California, San Francisco, San Francisco, USA., Kuderer NM; Advanced Cancer Research Group, LLC, Kirkland, USA., Kwon DH; University of California, San Francisco, San Francisco, USA., Lammers PE; Baptist Cancer Center, Memphis, USA., Li A; Baylor College of Medicine, Houston, USA., Loaiza-Bonilla A; Cancer Treatment Centers of America, Philadelphia, USA., Low CA; Intermountain Healthcare, Salt Lake City, USA., Lustberg MB; The Ohio State University, Columbus, USA., Lyman GH; University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, USA., McKay RR; University of California San Diego, Moores Cancer Center, La Jolla, USA., McNair C; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, USA., Menon H; Penn State Health/Penn State Cancer Institute/St. Joseph Cancer Center, Hershey, USA., Mesa RA; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, USA., Mico V; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, USA., Mundt D; Advocate Aurora Health, Milwaukee, USA., Nagaraj G; Loma Linda University Cancer Center, Loma Linda, USA., Nakasone ES; University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, USA., Nakayama J; Case Western Reserve University, Cleveland, USA; University Hospitals Cleveland Medical Center, Cleveland, USA., Nizam A; Cleveland Clinic Taussig Cancer Institute, Cleveland, USA., Nock NL; University Hospitals Seidman Cancer Center, Cleveland, USA; Case Western Reserve University, Cleveland, USA., Park C; University of Cincinnati Cancer Center, Cincinnati, USA., Patel JM; Beth Israel Deaconess Medical Center, Boston, USA., Patel KG; University of California Davis Comprehensive Cancer Center, Sacramento, USA., Peddi P; Willis-Knighton Cancer Center, Shreveport, USA., Pennell NA; Cleveland Clinic Taussig Cancer Institute, Cleveland, USA., Piper-Vallillo AJ; Beth Israel Deaconess Medical Center, Boston, USA., Puc M; Virtua Health, Marlton, USA., Ravindranathan D; Winship Cancer Institute of Emory University, Atlanta, USA., Reeves ME; Loma Linda University Cancer Center, Loma Linda, USA., Reuben DY; Medical University of South Carolina, Charleston, USA., Rosenstein L; Gunderson Health System, La Crosse, USA., Rosovsky RP; Massachusetts General Hospital, Harvard Medical School, Boston, USA., Rubinstein SM; University of North Carolina, Chapel Hill, USA., Salazar M; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, USA., Schmidt AL; Dana-Farber Cancer Institute, Boston, USA., Schwartz GK; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, USA., Shah MR; Rutgers Cancer Institute of New Jersey, New Brunswick, USA., Shah SA; Stanford University, Stanford, USA., Shah C; University of Florida, Gainesville, USA., Shaya JA; University of California San Diego, Moores Cancer Center, La Jolla, USA., Singh SRK; Henry Ford Cancer Institute/Henry Ford Health System, Detroit, USA., Smits M; ThedaCare Regional Cancer Center, Appleton, USA., Stockerl-Goldstein KE; Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA., Stover DG; The Ohio State University, Columbus, USA., Streckfuss M; Advocate Aurora Health, Milwaukee, USA., Subbiah S; Stanley S. Scott Cancer Center, LSU Health Sciences Center, New Orleans, USA., Tachiki L; University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, USA., Tadesse E; Advocate Aurora Health, Milwaukee, USA., Thakkar A; Albert Einstein Cancer Center/Montefiore Medical Center, Bronx, USA., Tucker MD; Vanderbilt University Medical Center, Nashville, USA., Verma AK; Albert Einstein Cancer Center/Montefiore Medical Center, Bronx, USA., Vinh DC; McGill University Health Centre, Montréal, Canada., Weiss M; ThedaCare Regional Cancer Center, Appleton, USA., Wu JT; Stanford University, Stanford, USA., Wulff-Burchfield E; Mount Auburn Hospital, Cambridge, USA., Xie Z; Mayo Clinic Cancer Center, Rochester, USA., Yu PP; Hartford HealthCare, Hartford, USA., Zhang T; Duke University, Durham, USA., Zhou AY; Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA., Zhu H; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, USA., Zubiri L; Massachusetts General Hospital, Harvard Medical School, Boston, USA., Shah DP; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, USA., Warner JL; Vanderbilt University Medical Center, Nashville, USA., Lopes G; University of Miami/Sylvester Comprehensive Cancer Center, Miami, USA.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Jun; Vol. 32 (6), pp. 787-800. Date of Electronic Publication: 2021 Mar 19.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Neoplasms*/drug therapy , Neoplasms*/epidemiology, Aged ; COVID-19 Testing ; Female ; Humans ; Male ; Pandemics ; SARS-CoV-2

المؤلفون: Ammann AM; Cincinnati, OH., Shah SA; Cincinnati, OH.

المصدر: Journal of the American College of Surgeons [J Am Coll Surg] 2021 Jun; Vol. 232 (6), pp. 933-934.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: Lippincott Williams & Wilkins, Inc Country of Publication: United States NLM ID: 9431305 Publication Model: Print Cited Medium: Internet ISSN: 1879-1190 (Electronic) Linking ISSN: 10727515 NLM ISO Abbreviation: J Am Coll Surg Subsets: MEDLINE

مواضيع طبية MeSH: Delivery of Health Care* , Neoplasms*/surgery, Hospital Mortality ; Humans

المؤلفون: Wu JT; Department of Medical Oncology, Stanford University, Stanford, CA., Kwon DH; Department of Medical Oncology, University of California, San Francisco, San Francisco, CA., Glover MJ; Department of Internal Medicine, Stanford University, Stanford, CA., Henry S; Department of Biomedical Data Science, Stanford University, Stanford, CA., Wood D; Department of Biomedical Data Science, Stanford University, Stanford, CA., Rubin DL; Department of Biomedical Data Science, Stanford University, Stanford, CA., Koshkin VS; Department of Medical Oncology, University of California, San Francisco, San Francisco, CA., Schapira L; Department of Medical Oncology, Stanford University, Stanford, CA., Shah SA; Department of Medical Oncology, Stanford University, Stanford, CA.

المصدر: JCO oncology practice [JCO Oncol Pract] 2021 Mar; Vol. 17 (3), pp. e377-e385. Date of Electronic Publication: 2020 Dec 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*administration & dosage , COVID-19/*therapy , Neoplasms/*therapy , Radiotherapy/*statistics & numerical data , Surgical Procedures, Operative/*statistics & numerical data , Time-to-Treatment/*statistics & numerical data, Administration, Oral ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; COVID-19/complications ; California ; Child ; Child, Preschool ; Female ; Humans ; Infusions, Intravenous ; Injections, Intramuscular ; Male ; Middle Aged ; Neoplasms/complications ; Neoplasms/diagnosis ; Palliative Care ; Retrospective Studies ; SARS-CoV-2 ; Time Factors ; Young Adult

المؤلفون: Shah SA; Amity Institute of Biotechnology, Amity University, Navi Mumbai, Maharashtra, India., Gupta AS; Amity Institute of Biotechnology, Amity University, Navi Mumbai, Maharashtra, India., Kumar P; Amity Institute of Biotechnology, Amity University, Navi Mumbai, Maharashtra, India.

المصدر: Journal of cancer research and therapeutics [J Cancer Res Ther] 2021 Jan-Mar; Vol. 17 (1), pp. 1-9.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Medknow Publications Country of Publication: India NLM ID: 101249598 Publication Model: Print Cited Medium: Internet ISSN: 1998-4138 (Electronic) Linking ISSN: 19984138 NLM ISO Abbreviation: J Cancer Res Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*adverse effects , Cannabinoid Receptor Agonists/*therapeutic use , Cannabinoids/*therapeutic use , Nausea/*drug therapy , Neoplasms/*drug therapy , Neuralgia/*drug therapy, Antineoplastic Agents/administration & dosage ; Humans ; Nausea/chemically induced ; Nausea/metabolism ; Neuralgia/chemically induced ; Neuralgia/metabolism ; Receptors, Cannabinoid/metabolism

المؤلفون: Shah SA; Department of Community Health, UKM Medical Centre, Kuala Lumpur, Malaysia., Mahmood MI; Department of Community Health, UKM Medical Centre, Kuala Lumpur, Malaysia.; Disease Control Division, Ministry of Health Malaysia, Health State of Wilayah Persekutuan Kuala Lumpur, Kuala Lumpur, Malaysia., Ahmad N; Department of Community Health, UKM Medical Centre, Kuala Lumpur, Malaysia.

المصدر: Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2020 Nov 01; Vol. 21 (11), pp. 3137-3144. Date of Electronic Publication: 2020 Nov 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Asian Pacific Organization for Cancer Prevention Country of Publication: Thailand NLM ID: 101130625 Publication Model: Electronic Cited Medium: Internet ISSN: 2476-762X (Electronic) Linking ISSN: 15137368 NLM ISO Abbreviation: Asian Pac J Cancer Prev Subsets: MEDLINE

مواضيع طبية MeSH: Health Knowledge, Attitudes, Practice* , Patient Acceptance of Health Care* , Social Class* , Socioeconomic Factors*, Early Detection of Cancer/*psychology , Early Detection of Cancer/*statistics & numerical data , Neoplasms/*diagnosis, Adult ; Cross-Sectional Studies ; Female ; Follow-Up Studies ; Humans ; Male ; Neoplasms/psychology ; Perception ; Risk Factors

المؤلفون: Rivera DR; Division of Cancer Control and Population Sciences, NCI, Rockville, Maryland., Peters S; Department of Oncology, University of Lausanne, Lausanne, Switzerland., Panagiotou OA; Department of Health Services, Policy and Practice, Brown University, Providence, Rhode Island., Shah DP; Department of Population Health Sciences, Mays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, Texas., Kuderer NM; Advanced Cancer Research Group, LLC, Kirkland, Washington., Hsu CY; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Rubinstein SM; Deparment of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Lee BJ; Deparment of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., de Lima Lopes G Jr; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Grivas P; Department of Medicine, Division of Oncology, University of Washington, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington., Painter CA; Count Me In, Cambridge, Massachusetts., Rini BI; Deparment of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Thompson MA; Advocate Aurora Health, Milwaukee, Wisconsin., Arcobello J; Karmanos Cancer Institute, Detroit, Michigan., Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Doroshow DB; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Egan PC; Department of Medicine, Division of Hematology/Oncology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island., Farmakiotis D; Department of Medicine, Division of Infectious Diseases, The Warren Alpert Medical School of Brown University, Providence, Rhode Island., Fecher LA; Department of Internal Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan., Friese CR; School of Nursing, University of Michigan, Ann Arbor, Michigan., Galsky MD; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Goel S; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York., Gupta S; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio., Halfdanarson TR; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Halmos B; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York., Hawley JE; Department of Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York., Khaki AR; Department of Medicine, Division of Oncology, University of Washington, Seattle, Washington., Lemmon CA; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio., Mishra S; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee., Olszewski AJ; Department of Medicine, Division of Hematology/Oncology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island., Pennell NA; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio., Puc MM; Department of Surgery, Section of Thoracic Surgery, Virtua Health, Marlton, New Jersey., Revankar SG; Karmanos Cancer Institute, Detroit, Michigan., Schapira L; Department of Medicine, Division of Oncology, Stanford University, Palo Alto, California., Schmidt A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schwartz GK; Department of Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York., Shah SA; Department of Medicine, Division of Oncology, Stanford University, Palo Alto, California., Wu JT; Department of Medicine, Division of Oncology, Stanford University, Palo Alto, California., Xie Z; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Yeh AC; Department of Medicine, Division of Oncology, University of Washington, Seattle, Washington., Zhu H; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Shyr Y; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Lyman GH; Fred Hutchinson Cancer Research Center, Seattle, Washington., Warner JL

مؤلفون مشاركون: COVID-19 and Cancer Consortium

المصدر: Cancer discovery [Cancer Discov] 2020 Oct; Vol. 10 (10), pp. 1514-1527. Date of Electronic Publication: 2020 Jul 22.

نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

مواضيع طبية MeSH: Coronavirus Infections/*drug therapy , Drug Utilization/*statistics & numerical data , Healthcare Disparities/*statistics & numerical data , Neoplasms/*mortality , Pneumonia, Viral/*drug therapy, Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/therapeutic use ; Age Factors ; Aged ; Alanine/analogs & derivatives ; Alanine/therapeutic use ; Betacoronavirus/pathogenicity ; COVID-19 ; Clinical Decision-Making ; Coronavirus Infections/complications ; Coronavirus Infections/diagnosis ; Coronavirus Infections/mortality ; Drug Therapy, Combination/methods ; Drug Therapy, Combination/statistics & numerical data ; Follow-Up Studies ; Glucocorticoids/therapeutic use ; Hospital Mortality ; Humans ; Hydroxychloroquine/therapeutic use ; Male ; Middle Aged ; Neoplasms/complications ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/mortality ; Risk Factors ; SARS-CoV-2 ; Severity of Illness Index ; Sex Factors ; Treatment Outcome ; United States/epidemiology ; COVID-19 Drug Treatment

المؤلفون: Schapira MM; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Center for Health Equity Research and Promotion (CHERP), Philadelphia VA Medical Center, Philadelphia, Pennsylvania, USA., Stevens EM; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Sharpe JE; Center for Outcomes Resarch, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Hochman L; Center for Outcomes Resarch, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Reiter JG; Center for Outcomes Resarch, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Calhoun SR; Center for Outcomes Resarch, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Shah SA; Center for Outcomes Resarch, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Bailey LC; Division of Oncology, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Bagatell R; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Oncology, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Silber JH; Center for Outcomes Resarch, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Oncology, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Health Care Management, Wharton School, The University of Pennsylvania, Philadelphia, Pennsylvania, USA., Tai E; Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Barakat LP; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Oncology, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

المصدر: Cancer [Cancer] 2020 Aug 01; Vol. 126 (15), pp. 3471-3482. Date of Electronic Publication: 2020 May 26.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Pediatrics* , Prognosis*, Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Neoplasms/*drug therapy, Adolescent ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Child ; Child, Preschool ; Cohort Studies ; Disease-Free Survival ; Female ; Humans ; Infant ; Leukemia, Myeloid, Acute/drug therapy ; Leukemia, Myeloid, Acute/epidemiology ; Leukemia, Myeloid, Acute/pathology ; Male ; Neoplasms/epidemiology ; Neoplasms/pathology ; Neuroblastoma/drug therapy ; Neuroblastoma/epidemiology ; Neuroblastoma/pathology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/epidemiology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Retrospective Studies ; Rhabdomyosarcoma/drug therapy ; Rhabdomyosarcoma/epidemiology ; Rhabdomyosarcoma/pathology ; Treatment Outcome ; United States/epidemiology ; Young Adult